General form of registration statement for all companies including face-amount certificate companies

Note 11 - Stock and Employee Benefit Plans 1 (Details Textual)

v3.24.4
Note 11 - Stock and Employee Benefit Plans 1 (Details Textual) - Pieris Pharmaceuticals, Inc. [Member] - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Jun. 21, 2023
Jun. 20, 2023
Jun. 22, 2022
Jun. 25, 2021
Dec. 31, 2023
Dec. 31, 2022
Sep. 30, 2024
Dec. 31, 2020
Jun. 23, 2020
Common Stock, Capital Shares Reserved for Future Issuance (in shares)         9,375        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)         46,677 38,498      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value (in dollars per share)         $ 97.34 $ 230.29      
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant (in shares)         116,060        
Stock Issued During Period, Shares, Employee Stock Purchase Plans (in shares)         1,933 2,268      
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount         $ 4.3        
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)         2 years 2 months 26 days        
Share-Based Payment Arrangement, Option [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent         85.00%        
Employee Director And Consultant Equity Incentive Plan2020 [Member]                  
Common Stock, Capital Shares Reserved for Future Issuance (in shares)   184,375   71,875         43,750
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized (in shares) 75,000 75,000 37,500 28,125          
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)           10 years      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)         46,677        
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant (in shares)             333,145 19,746